Ausgabe 3/2001
Inhalt (10 Artikel)
Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines
Katherine Ory, Jérôme Lebeau, Céline Levalois, Karine Bishay, Pierre Fouchet, Isabelle Allemand, Amu Therwath, Sylvie Chevillard
Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose
Pehr A.R.M Lind, Berit Wennberg, Giovanna Gagliardi, Tommy Fornander
Altered expression and localization of PKC eta in human breast tumors
P.A. Masso-Welch, J.S. Winston, S. Edge, K.M. Darcy, H. Asch, M.M. Vaughan, M.M. Ip
Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat
Claus Holst-Hansen, Jennifer A. Low, Ross W. Stephens, Michael D. Johnson, Peter Carmeliet, Thomas L. Frandsen, Nils Brünner, Robert B. Dickson
Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicators
H. Bozcuk, G. Uslu, E. Peştereli, M. Samur, M. Ozdoğan, Ş Karaveli, F. Sargın, B. Savaş
Clinical relevance of biologic factors in male breast cancer
Marion E. Meijer-van Gelder, Maxime P. Look, Joan Bolt-de Vries, Harry A. Peters, Jan G.M. Klijn, John A. Foekens
Does breast cancer grade worsen with time? Evidence from breast screening
Ann Johnson, Jane Shekhdar
The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively
Samantha Coster, Karen Poole, Lesley J Fallowfield